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A  specific antigen  (S antigen)  induced by poxvirus was found  on  the  surface of 
vaccinia-infected cells by use of immunofluorescence (1) or immune hemadsorption (2). 
S-specific antibody,  which  stained  by  immunofluorescence  the  S  antigen  but  not 
cytoplasmic inclusions of vaccinia-infected cells, was prepared by immunizing rabbits 
with rabbit kidney cells infected with a conditional lethal mutant of vaccinia virus (3). 
This mutant  (4)  grows well in the  chorioallantoic membrane  of embryonated hens' 
eggs as well as in chick embryo cell cultures, but fails to induce viral DNA and late 
protein syntheses in rabbit kidney and HeLa cells, although early antigens detectable 
by immunofluorescence or complement fixation are produced. The soluble early antigen 
preparation made from mutant-infected HeLa cells also elicited in rabbits the produc- 
tion of antibody of the same nature. These immune sera contained complement-fixing 
and  precipitating  antibodies  against  vaccinia-soluble antigens,  but  no  detectable 
neutralizing antibody (3). Although the relationship between the antigen(s) responsible 
for surface immunofluorescence of infected cells (S antigen) and those for complement 
fixation or immunodiffusion remains to be elucidated, the above data indicate that 
the soluble early antigen preparation made from mutant-infected HeLa cells contained 
the S antigen, but not the antigen(s) concerning the induction of vaccinia-neutralizing 
antibody. This  led  the  authors  to  examine  the  immunological role  of  this antigen 
preparation in animals against vaccinial infection, and the present paper deals with 
the induction of skin resistance to vaccinia virus, probably of cell-mediated type, in 
rabbits by  this antigen preparation without  eliciting the  production  of  circulating 
neutralizing antibody. The antigen preparation used here may contain more than one 
antigen, but not all of the early antigens produced in vaccinia-infected cells as will be 
discussed later. The antigen preparation will be referred to as the Es antigen  (vac- 
cinia-soluble early antigen preparation including the S antigen) in the text. 
Materials and Methods 
Viruses.--DI  strain of vaccinia virus and a conditional lethal mutant derived from it, Dis 
strain (4), were propagated in the chorioallantoic membrane  (CAM)1 of embryonated hens' 
eggs. Vaccinia  virus used for intradermal challenge  of rabbits was a commercial  lot of calf 
lymph vaccine prepared with the Ikeda strain of vaccinia virus. Extracellular vaccinia virus 
1  Abbreviations used in this paper: CAM, chorioallantoic  membrane; CE,  chick embryo; 
CF, complement fixation; MIF, migration inhibitory factor; m.o.i., multiplicity of infection; 
PFU, plaque-forming  units; p.i., postinfection;  VSV, vesicular stomatitis virus. 
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for neutralization test was obtained from DI virus-infected HeLa cell cultures as described by 
Appleyard et al.  (5). Vesicular stomatitis virus (VSV) was propagated in HeLa cell cultures. 
Cell Cultures.--HeLa  and  chick embryo  (CE)  cell  cultures were prepared as  described 
previously (1, 6).  RK-13, a cell line derived from rabbit kidney, was grown in synthetic 199 
medium supplemented with 5% bovine serum. 
Assay of Infectivity and Neutralizing Antibody.--Plaque  technique on CE monolayers was 
used for vaccinia virus as described earlier (3, 6).  VSV was titrated in RK-13 cell cultures 
under agar overlay consisting of 199 medium with 4% bovine serum, 0.002% neutral red, and 
1.2% Noble agar. Plaques were counted 4 days postinfection (p.i.). 
Preparation of Vaccinia-Soluble Early Antigens (Es Antigen).--The method was described 
in a previous report (3). Briefly,  HeLa cells were infected with the conditional lethal mutant 
at an input multiplicity of infection (m.o.i.)  of 10 plaque-forming units  (PFU)/cell in the 
presence of cytosine arabinoside at 20 #g/ml to block a leak of the late antigen synthesis that 
was observed in a few percent of cells when infected at a high m.o.i., and 18 h later cells were 
scraped off into the medium with a  rubber policeman. The cell suspension was clarified  by 
centrifugation, concentrated by acetone precipitation, and served as the soluble early antigen 
preparation (Es antigen). No infectivity  could be found in the Es antigen thus prepared. Mock- 
infected HeLa cell cultures were treated similarly and served as a control antigen. The protein 
content of the antigen preparations was determined by Lowry's method  (7).  Es  antigen 
preparation used for immunization contained 420 #g/ml of protein with CF antigen fiter of 
1:64 against antivaccinia serum, while host cell antigen preparation contained 680/zg/ml of 
protein without any cross CF reactivity with vaccinia antiserum. 
Complement-Fixation (CF) Test.--The micromethod in a disposable tray (8) was used. 
Immunization  of Rabbits.--Albino  rabbits of about 2 kg of body weight were immunized 
with antigen preparations with or without Freund's complete adjuvant. Two injections of 2 ml 
each of the antigen were given subcutaneously or intramuscularly at an interval of 2-3 wk. 
When used with adjuvant, the antigen was mixed with an equal volume of Freund's complete 
adjuvant and 4 ml each of the mixture was injected. Sera were obtained from each rabbit 
before immunization, and before and 4 wk after virus challenge. 
Challenge of Rabbits with Vaccinla Virus.--At a specified time interval after immunization 
each rabbit was inoculated intradermally with 200 PFU each of the Ikeda strain of vaccinia 
virus in 0.2 ml into four spots on the shaved back. After 5-6 days the skin of two inoculated 
sites (3 cm 2 each) was e~cised to quantificate the amount of virus multiplied. 
Interferon Assay.--A portion of the skin of immunized rabbits was excised at a  specified 
interval. A 10% homogenate was prepared and assayed for interferon activity. The homogenate 
was inoculated onto RK-13 monolayers and incubated at 36°C for 24 h. The cell cultures were 
then washed and inoculated with VSV. Plaques were counted after 4 days at 36°C and inter- 
feron activity was expressed as reciprocals of the highest dilution of the preparation that 
reduced plaque number to 50%  of those of virus control. In each test the titration of the 
standard rabbit skin interferon preparation diluted to 16 U with a  10%  homogenate of the 
skin of a  normal rabbit was set up in parallel to check the dependability of the test. The 
standard interferon preparation from the rabbit skin was kindly provided by Dr. Y. Kojima, 
Kitasato Institute, Tokyo. 
Production of Migration Inhibitory  Factor (MIF)  and Macrophage Migration Inhibition 
,4ssay.--These  were carried out by the method described by Rocklin et al.  (9)  with minor 
modification. Cell preparation consisting of more than 95% circulating lymphocytes from an 
immune rabbit was cultured at 37°C in a CO2 incubator in the presence or absence of the Es 
antigen. 24 h later, the cells were removed by a light centrifugation. The superuatants were 
stored at --70°C until tested in vitro for the migration inhibition of guinea pig macrophages. 
The Es antigen used for MIF induction had a CF antigen titer of 1:128  against an antivac- 
cinia-soluble early antigen rabbit serum, but less than 1:8 against an anti-HeLa cell antigen 
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Peritoneal exudate cells from normal guinea pigs were induced by intraperitoneal injection 
of Drakeol no. 35. The cells were washed in Eagle's medium and suspended to 8% by volume 
in Eagle's medium supplemented with 20% calf serum.  Capillary tubes were filled with the 
cell suspension and centrifuged to obtain cell packs. The tubes were cut and the portion con- 
raining the cells was placed in micro Petri dishes. The chambers were filled with the super- 
natants of lymphocyte cultures to be assayed and incubated at 37°C for 48 h  in a  CO2 incu- 
bator. The area of migration was projected and measured by planimetry, and percent migra- 
tion inhibition was calculated: 
X--  Y 
percent  migration  inhibition  -  X  X  100, 
where X  is the area of migration in the supernatant of lymphocyte cultures without antigen 
and Y is the area of migration in the supernatant of lymphocyte cultures with antigen. 
RESULTS 
Antibody  Response  of Rabbits  Immunized  with  the  Es Antigen  of  Vaccinia- 
Infected Cells.--Immunization  of rabbits  with  the Es antigen  in Freund's  com- 
plete  adjuvant  did  not  induce  detectable  circulating  neutralizing  antibody 
against either intracellular or extracellular vaccinia virus (Table I). These  sera, 
TABLE  I 
Response of Rabbits Immunized with Vaccinia-Soluble Early Antigens in Freund's Complete 
Adjuvant to [ntradermal Inoculation of Vaccinia Virus 
Interval  Serum  obtained  Skin reaction (diameter of 
between  before virus  erythema) ~  Virus con-  Serum  4 
Autigen .used for  the last  challenge  Day(s) p.i.  tents of the 
immumzation  shot and  skin§ 6 days  wk p.i. 
virus  NT*  CF*  1  2  4  6  p.i.  NT]I 
challenge 
wk  rnm  log PFU 
Es antigen in  2  <4  32  8  12  12  10  < 1.7  <4 
Freund's corn-  <4  16  12  ~  13  <1.7  <4 
plete adjuvant  <4  128  8  20  __16  10  2.3  4 
<4  128  ~  13  17  8  <1.7  4 
6  <4  32  7  16  24  10  4.2  16 
< 4  64  4  15  16  12  4.5  16 
Control HeLa  2  <4  <8  --  --  19  25  6.4  256 
cell antigen in  <4  <8  --  q-  2"0  1~  6.2  256 
Freund's corn-  < 4  < 8  --  ~  1-5  1-'8  7.2  256 
plete adjuvant  <4  <8  --  ~:  15  28  7.3  256 
None  --  <4  <8  --  --  16  19  5.7  N.D. 
<4  <8  --  --  13  22  6.3  N.D. 
*  NT:  Neutralizing  antibody  against  extracellular  and  intracellular  vaccinia  virus  as 
measured by 50% plaque reduction in CE cultures. CF: Complement-fixing antibody against 
vaccinia soluble antigen (CAM). 
:~ Underline means erythema with induration. 
§ About 3 cm  ~ each of the skin around two inoculation sites was excised and a  10% homog- 
enate was made. Virus titer was expressed as log PFU per one inoculation site (3 cm2). 
I[ NT:  Only neutralizing antibody against CAM  virus preparation  consisting of mainly 
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however, fixed complement when  reacted  with  the  soluble  antigens  of vac- 
cinia-infected cells (CAM). Neither neutralizing antibody nor vaccinia-specific 
CF antibody were detectable in  the sera of nonimmune rabbits or those im- 
munized with the control host cell antigen. 
Skin Reaction and  Virus  Growth in  the Skin of Immune Rabbits by Intra- 
dermal Inoculation of Vaccinia Virus.--At specified time intervals after the last 
immunizing shot each rabbit was inoculated intradermally with 200 PFU each 
of vaccinia virus as described in Materials and Methods. Rabbits immunized 
with the Es antigen responded to the virus challenge with an earlier appearance 
of erythema at the inoculation site compared with nonimmune rabbits or those 
treated with the control antigen. Erythema in the  skin  of immunized rabbits 
later became accompanied with induration, which was not so prominent and 
tended to wane from 5 to 6 days p.i., although faint reddening of the skin still 
remained in some rabbits up to 6  days p.i.  In  contrast,  the skin reaction in 
control nonimmune or host cell antigen-treated rabbits took a  typical course, 
showing an appearance of recognizable erythema and induration at the inocula- 
tion sites from 3 to 4 days p.i., which increased their intensity up to 6 days p.i. 
with  typical  lesions  characterized  by  intense  induration  accompanied  with 
central  necrosis.  The virus  contents  of the  skin  around  the  inoculation site 
were assayed 6 days p.i. Results of one of the replicate experiments are shown 
in Table I. The virus propagation was greatly inhibited in the skin of rabbits 
immunized with the Es antigen, compared with those in control rabbits. The 
neutralizing antibody titers of the sera obtained 4 wk p.i. appeared to reflect 
the grade of virus replication in the skin of each rabbit. It was thus shown that 
the immunization of rabbits with the Es antigen in Freund's complete adjuvant 
induced resistance to intradermal inoculation of vaccinia virus without eliciting 
the production of detectable circulating neutralizing antibody. 
Replicate experiments indicated that  the  resistance of immunized animals 
could be observable from 1 to 6 wk (the longest interval examined) after the 
last immunizing shot, reaching its height 2-3 wk and declining thereafter. In- 
duction of skin  resistance  in  rabbits  was  not  influenced by the  route  (sub- 
cutaneous or intramuscular) or site (lower portion of the flank or thigh) of im- 
munization. 
Absence of Detectable Soluble Inhibitory  Substance of  Vaccinia  Virus  in  the 
Skin of Immunized  Rabbits.--Experiments  were carried out to examine a pos- 
sibility that interferon or any inhibitory substance of vaccinia virus existed in 
the skin of immunized animals that might account for the restricted multiplica- 
tion of vaccinia virus inoculated intradermally. A 10 % homogenate of the skin 
of two rabbits immunized with the Es antigen in Freund's complete adjuvant 
as well as of those treated with the host cell antigen was prepared. The supernate 
of the homogenate from either group of rabbits did not reduce the number of 
plaques produced by vaccinia virus in  CE cultures nor contained any inter- 
feron activity when assayed in RK-13 cell cultures by use of VSV. The standard ¥.  UEDA  AND  I.  TAGAYA  1037 
interferon preparation diluted to 16 U with a  10% homogenate of the skin of a 
normal rabbit was titrated in parallel and it was confirmed that the skin homog- 
enate did not reduce the interferon activity. Another experiment was designed 
to examine a  possibility that intradermal inoculation of vaccinia virus might 
induce  interferon earlier in immunized rabbits than in control  animals. Two 
rabbits immunized with  the Es antigen  in  Freund's complete adjuvant were 
inoculated with 200 PFU each of vaccinia virus intradermally into four spots 
on the back 2 wk after the last immunizing shot. The skin of immunized animals 
around the site of vaccinia inoculation was excised 24 h p.i. and a  10 % homog- 
enate was prepared.  The homogenate clarified  by a  light  centrifugation  was 
acid  treated at  4°C  for 3  days, neutralized with N  NaOH,  and diluted  1:10 
with Eagle's medium containing antivaccinia serum. This rather long treatment 
of the homogenate with acid followed by dilution with the medium containing 
antiserum was necessary, because vaccinia virus  in a 10% rabbit skin homog- 
enate was more stable to acid treatment  than  in  a  less  proteinous  suspend- 
ing medium.  The  standard  rabbit  skin  interferon preparation  diluted  to  16 
U  with a  10 %  normal rabbit skin homogenate was treated in the same man- 
ner.  They  were  assayed for interferon activity in RK-13 cell cultures  against 
plaque  formation  by VSV.  The  skin  homogenates  from  immunized  animals 
showed no interferon activity, while the standard interferon preparation treated 
in the same manner showed no significant loss of activity. 
Inability  of Antisoluble  Early  Antigen  Rabbit  Sera  to  Passivdy  Immunize 
Normal Rabbits against Intradermal  Inoculation of Vaccinia  Virus.--Although 
sera from rabbits immunized with the Es antigen in Freund's complete adjuvant 
did not contain detectable neutralizing antibody against either intracellular or 
extracellular vaccinia virus, a possibility should be considered that the serum 
may be effective in vivo in conjunction with complement or any other cofactor 
to inhibit  the multiplication of vaccinia virus. The serum from three rabbits 
immunized with  the  Es  antigen  was transferred  to four normal  rabbits sub- 
cutaneously and intradermally. Each rabbit received 4 ml of the serum,  1 ml 
each subcutaneously on the lower portion of each flank, and 0.2 ml each intra- 
dermally in 10 spots around the four sites to be inoculated with vaccinia virus. 
As controls two other rabbits received the same amount of rabbit serum against 
host cell antigen and four rabbits received the same amount of hyperimmune 
serum from two rabbits obtained by dermal infection with vaccinia virus.  6 h 
after the  serum  transfer  each  rabbit was  inoculated  intradermally into  four 
spots  with  200  PFU  each  of vaccinia virus.  Rabbits  that  received  immune 
serum against either the Es antigen or HeLa cell antigen showed the typical 
primary skin reaction of vaccinia infection. Although there were some variations 
in the size of induration and local virus contents 5 days p.i., they were within 
the range of reactivities of normal rabbits. On the contrary those that received 
antivaccinia immune serum showed complete refistance to intradermal inocula 
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TABLE II 
Inability of Rabbit Sera against the Es A ntlgen to Passively Immunize Normal Rabbits against 
Intradermal Inoculation of Vaccinia Virus 
Code of  Neutralizing  Induration  Virus contents 
Nature  donor rabbit*  antibody titer~:  5 days p.i.  5 days p.i. 
Anti-Es antigen  (with 
Freund's complete 
adjuvant) 
mm  log PFU 
A09  <4  16  7.3 
A10  <4  13  5.7 
A24  <4  13  6.0 
A24  <4  11  5.4 
Anti-HeLa cell antigen  (with  A15 
Freund's complete  A16 
adjuvant) 
Antivaccinia 
<4  20  7.1 
<4  19  6.9 
S-22  4,096  0  < 1.7 
S-22  4,096  0  < 1.7 
S-18  1,024  0  < 1.7 
S-18  1,024  0  <1.7 
* Rabbits nos. A09, A10, A15, and A16 correspond  to the first two rabbits  each in E~ 
antigen and HeLa cell groups, respectively, in Table I. Rabbit A24 was immunized with E~ 
antigen for another experiment. 
:~ Measured with the conventional-infected CAM homogenate. 
Induction of MIF by Lymphocytes from Es A ntigen-Immunized Rabbits.--The 
results of the preceding experiments suggested that the resistance against intra- 
dermal  inoculation  of vaccinia virus induced  in rabbits  by the  Es  antigen  in 
Freund's complete adjuvant may not be due  to the humoral  antibody but of 
cell-mediated type. Two rabbits each were immunized with two intramuscular 
injections at an interval of 2 wk either with the Es antigen or with the control 
HeLa cell antigen in combination with Freund's complete adjuvant. Blood was. 
withdrawn from each rabbit 2 wk after the last injection, and lymphocytes were 
cultured  with  or  without  the  Es  antigen  as  described  in  the  Materials  and 
Methods.  The supernate  of the culture fluids obtained 24 h  later was assayed 
for the migration inhibition of guinea pig peritoneal macrophages. As shown in 
Table III, lymphocytes from rabbits immunized with the Es antigen produced 
MIF in the presence of the Es antigen, whereas those from control rabbits im- 
munized with the host cell antigen did not. 
Response  of  Rabbits  Immunized  with  the  Es  Antigen  without  Adjuvant  to 
Intradermal Inoculation  of  Vaccinia  Virus.--The  immunizing effect of the Es 
antigen  without  adjuvant  was  then  examined.  Rabbits  were  given  two  sub- 
cutaneous  or  intramuscular  injections  of  the  antigen.  At  specified  intervals 
after  the  last  injection  the  animals  were  inoculated  intradermally  with  200 
PFU each of vaccinia virus in four spots on the shaved back. The results of one 
of the  typical  experiments  are  shown  in  Table  IV.  The  circulating  antibody Y.  UEDA  AND  I.  TAGAYA 
TABLE  III 
Induction of MIF by Lymphocytes  of Rabbits Immunized with the Es Antigen 
1039 
Source of lymphocytes  Code of  Antigen  for  Area  of migration Percent migration 
donor rabbit  MIF induction  of macrophages  inhibition 
Rabbit immunized with the Es  7121  Yes  919 
antigen in Freund's complete  No  1,148 
adjuvant  7122  Yes  826 
Rabbit immunized with control  7123 
HeLa cell antigen in Freund's 
complete adjuvant  7124 
% 
23.4 
31.6 
No  1,211 
Yes  1,465  --11.5 
No  1,313 
Yes  1,457  --8.2 
No  1,348 
TABLE  IV 
Response  of Rabbits  Immunized  with  Vaccinia-Soluble  Early  Antigens  without  Adjuvant  to 
Intradermal  Inoculation  of Vaccinia Virus 
Interval  Serum  with-  Skin reaction (diameter of 
between  drawn  before  erythema);~ 
the last  virus challenge  at day  Immunization  shot and 
virus  NT][  CF*  1  2  4  6  challenge 
Virus  Serum  4 
contents  wk after 
of the  challenge 
skin§ 6  NTII 
days p.i. 
Two subcutaneous 
injections of the 
Es antigen at an 
interval of 2 wk 
Two intramuscular 
injections of the 
Es antigen at an 
interval of 3 wk 
wk 
3 
mm 
<4  16  20  30  cfl¶  cfl 
<4  8  19  32  cfl  cfl 
< 4  32  2--9  3-8  3--9  c'-fl 
<4  8  26  40  cfl  cfl 
<4  8  19  30  36  18 
<4  8  10  21  16  12 
8.1  1,024 
8.4  4,096 
6.3  256 
8.0  ND** 
5.4  64 
4.9  256 
*, ~, §, 11 See footnotes in Table I. 
¶  cfl: Confluent lesion with inflammation of hemorrhagic nature. 
** Not done because serum was not available due  to an accidental death of the rabbit 
before 4 wk p.i. 
response  was  not  so  different  from  those  immunized  with  Freund's  complete 
adjuvant.  The  local reaction,  however,  was  characterized by  a  heavier edema 
and  erythema  around  the inoculation site,  which was  very marked  even 24 h 
p.i.  The  lesion progressed  gradually to become confluent in some rabbits with 
those  of  neighboring  inoculation  sites  and  covered  a  broad  area  of  the  back 
accompanied  by  hemorrhage  and  partial  necrosis  3  days  p.i.  and  thereafter. 
The  virus contents of the skin were rather higher than those of nonimmunized 
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a  milder local reaction, which tended to wane from 5 days p.i. The virus con 
tents of the skin were also not so different from those of nonimmune or ho~t cell 
antigen-immunized control rabbits in the preceding experiments. Neutralizing 
antibody in the sera withdrawn 4 wk p.i. again appeared to reflect the grade of 
local reactions or virus contents of the skin. 
DISCUSSION 
Evidence has been accumulated both clinically (10,  11) and experimentally 
(12-14)  that  cell-mediated immune  responses play an  important  role in  the 
resolution of vaccinial lesions, while neutralizing antibody only is not always 
fully effective on the recovery of animals from vaccinia virus infection. Various 
attempts have been made in  assessing  the relative contributions of humoral 
and cellular type of immunological mechanisms to resistance to vaccinial in- 
fections (12-19).  Hirsch et al.  (14)  demonstrated that  antimouse thymocyte 
rabbit  serum  suppressed  in  mice host  cell-mediated responsiveness to  intra- 
venously administered vaccinia virus, thereby augmenting the morbidity and 
mortality of this infection, while it did not affect either humoral antibody or 
interferon production in response to vaccinia virus. Turk et al.  (12)  produced 
a  typical delayed hypersensitivity without demonstrable circulating antibody 
to vaccinia virus in guinea pigs by injection of virus-antiserum mixtures, and 
found that small reduction in the multiplication of vaccinia virus occurred in 
the presence of delayed hypersensitivity reactions, whether these were virus- 
specific or produced by an unrelated antigen. They concluded that this slight 
effect on virus multiplication was unlikely to play a  significant part in spon- 
taneous remission of vaccinia virus infection. Recently B landen (17-19) stressed 
again  the important role of cell-mediated immunity in the mechanism of re- 
covery of mice  from  generalized mousepox virus  infection.  A  contradictory 
report, however, was also published by Worthington et al.  (20)  on the effects 
of cyclophosphamide in systemic vaccinia virus infectio~ of mice, suggesting an 
essential role for humoral antibody, but not for cellular immunity, in recovery 
from primary vaccinia virus infection in the mouse. 
Vaccinia virus infection induces a number of virion antigens as well as soluble 
antigens, and it has not been elucidated which antigen(s) might be responsible 
for cellular immunity essential for the resolution of vaccinial lesions. Ueda and 
Nozima (21)  reported that the LS antigen was responsible for developing de- 
layed hypersensitivity, but it remains still unknown whether or not this antigen 
is effective in vivo as an inducer of cellular immunity effective against vaccinial 
infections. McNeil (22) described skin resistance and hypersensitivity in rabbits 
immunized  with  inactivated  vaccinia  virus,  especially when  combined  with 
polyvinylpyrrolidone, although variable neutralizing antibody responses were 
also observed, and he considered that skin resistance was related to the titer 
of circulating antibody rather than to the degree of delayed hypersensitivity. 
Boulter et al.  (23) suggested that inactivated intracellutar virus may induce a Y.  IYEDA  AND  I.  TAGAYA  1041 
cellular type of immunity, which is effective in protection of rabbits against a 
lethal disease by rabbitpox infection. 
In the present report we presented an evidence that  the immunization of 
rabbits with the vaccinia-soluble early antigens obtained from mutant-infected 
HeLa cells (Es antigen)  induced resistance in the rabbit against intradermal 
inoculation of vaccinia virus without eliciting demonstrable neutralizing anti- 
body production. Inhibition of the multiplication of virus in immune rabbits 
was evidenced by reduced virus contents in the skin of inoculation site as well 
as a lower neutralizing antibody response compared with those in control ani- 
mals. It seems unlikely that interferon played more favorable role to immunized 
animals in restricting the multiplication of virus in  the skin than to control 
animals. The resistance may be considered as of cell-mediated type, because 
serum from immune rabbits could not transfer the resistance to normal rabbits. 
Preliminary experiments on an attempt to transfer immunity to normal rabbits 
by lymphocytes from lymph nodes and the spleen of immunized rabbits were 
not successful. Lymphocytes of immune rabbits, however, induced MIF in the 
presence of the Es antigen. Earlier appearance of skin reaction in immunized 
animals than in control animals after intradermal inoculation of virus seems to 
suggest that delayed hypersensitivity reaction took place against early antigens 
produced  by  inoculated  virus.  Our  previous  data  indicated  that  vaccinia- 
specific soluble early antigens appear on the surface of infected cells before the 
commencement of viral DNA synthesis. Thus, infected cells could be recognized 
and attacked before progeny virions are produced within them, if cell-mediated 
immunity  is  strong  enough.  When  rabbits  were  immunized  with  the  same 
antigen  without  adjuvant,  an  enhanced  reaction  of  animals  was  observed 
against intradermal injection of vaccinia virus. The skin lesion was far more 
enhanced,  being accompanied by heavy induration,  hemorrhage,  and partial 
necrosis, and virus multiplication was also much exalted. This type of abnormal 
skin lesion has also been reported in some rabbits immunized with inactivated 
vaccinia virus (22). The reason why immunization without adjuvant resulted 
in  an  adverse  effect against  intradermal  vaccinia  infection remained  to  be 
elucidated, but a possibility might be that immunization without adjuvant may 
be insufficient to induced cellular immunity strong enough to inhibit the multi- 
plication of inoculated virus,  whereas  enhancing  antibody was  induced  that 
interfered with the induction and/or manifestation of cellular immunity. The 
existence of nonspecific antigen-antibody reaction, which may affect the perme- 
ability of peripheral blood vessels in tissues near the inoculation site,  should 
also be taken into consideration. 
Recently Ito and Barron  (24)  reported that a  strain of vaccinia virus was 
defective in surface antigen production. Their observation was confirmed by us 
and it was further revealed that a  few strains of variola-vaccinia group were 
defective in synthesizing the Es antigen (Ueda, Y., I. Tagaya, and H. Amano, 
data to be published). It was also found that  the Es antigen is a  portion of 1042  SKIN RESISTANCE TO VACCINIA VIRUS 
vaccinia early antigens and that the strains of variola-vaccinia group examined 
including those defective in synthesizing the Es antigen shared the other early 
antigens, which seemed, however, to be less abundant on the surface of infected 
cells (Tagaya, I., H. Amano, and Y. Ueda, unpublished observations). In the 
later stage of infection late antigens also become observable on the surface of 
infected cells.  All these antigens together with the virion antigens may be re- 
sponsible for the induction of immunity against vaccinia virus infection,  and 
further studies are required to elucidate the immunological roles played by each 
of these antigens.  The present report may be the first step for the studies of 
complicated vaccinial immunity from the point of the antigens concerned. 
SUMMARY 
The immunological role of vaccinia-soluble early antigen  was  examined  in 
rabbits.  The  antigens were prepared from HeLa cells infected  with  a  condi- 
tional lethal mutant of vaccinia virus, which induces in these cells early antigens 
including those responsible for surface immunofluorescence of infected cells, but 
not viral DNA and late protein syntheses.  Immunization of rabbits with  the 
antigens in Freund's  complete adjuvant induced  complement-fixing antibody 
but neither detectable circulating neutralizing antibody nor any detectable level 
of inhibitory substance or interferon in the skin of the animals. When immunized 
animals were  inoculated  intradermally with  vaccinia virus,  multiplication  of 
virus in  the skin was greatly inhibited,  being accompanied by an earlier  ap- 
pearance as well as an accelerated wane of the local reactions. The resistance 
could not be transferred passively by the serum of immunized animals to normal 
rabbits. Immunization of rabbits with  the antigens without the adjuvant not 
only failed to inhibit but,  contrariwise,  enhanced  the multiplication of intra- 
dermally inoculated  vaccinia virus,  inducing  heavy skin  lesions  and  exalted 
virus multiplication. 
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